(Q44393749)

2 December 2017

title

Zolpidem dependence case series: possible neurobiological mechanisms and clinical management (English)

1 reference

2 December 2017

I A Liappas

1

1 reference

2 December 2017

P N Malitas

2

1 reference

2 December 2017

N P Dimopoulos

3

1 reference

2 December 2017

O E Gitsa

4

1 reference

2 December 2017

A I Liappas

5

1 reference

2 December 2017

Ch K Nikolaou

6

1 reference

2 December 2017

G N Christodoulou

7

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Journal of Psychopharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

17

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

131-135

1 reference

Abuse, dependence, and epileptic seizures after zolpidem withdrawal: review and case report

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001723

Subtle changes in residue 77 of the gamma subunit of alpha1beta2gamma2 GABAA receptors drastically alter the affinity for ligands of the benzodiazepine binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001723

Benzodiazepine receptor binding of nonbenzodiazepines in vivo: alpidem, zolpidem and zopiclone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001723

Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001723

GABA(A)-receptor subtypes: clinical efficacy and selectivity of benzodiazepine site ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001723

Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001723

Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001723

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001723

Selective effects of zolpidem on human memory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001723

Alcohol and the brain. Pharmacological insights for psychiatrists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001723

Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001723

Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001723

Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001723

Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001723

Epidemiological evidence for a low abuse potential of zolpidem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103017001723

10.1177/0269881103017001723

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference